CD47 and neoplasm: Three different human tumor cell lines of MCF7, HT29 and Jurkat were offered to macrophages as target cells, and the results showed that pep-20 significantly increased macrophages-mediated phagocytosis of tumor cells, which was slightly inferior to the anti-CD47 antibody (B6H12) positive control (figure 1E–G).